Article

Ars Technica on 2020-09-02 02:32

National Institutes of Health disses FDA on plasma as COVID treatment

Internal dissent about the FDA's Emergency Use Authorization spills out in public.

Related news

FDA halts emergency approval of COVID-19 blood plasma treatment New York Post
FDA Grants Emergency Authorization to Use Plasma Treatment for Coronavirus slate.com
Mayo Clinic , Cranz
FDA gives blood plasma emergency use authorization for COVID-19 treatment Ars Technica
New York
Navarro’s push for plasma treatment goes further than FDA scientists POLITICO
FDA approves convalescent plasma treatment for Covid-19 bizjournals.com
FDA chief issues mea culpa for his plasma treatment claims POLITICO
Texas
DFDA Approves Convalescence Plasma Treatment For COVID-19 Patients dailyguidenetwork.com
FDA to authorize plasma treatment over scientists' objections POLITICO
Legaria
MFDA authorizes plasma treatment for COVID-19 patients marketwatch.com
MWhat to know about the blood plasma treatment approved by the FDA to fight COVID-19 miamiherald.com
White House , Philadelphia , China , Texas
FDA chief apologizes for overstating benefits of plasma treatment on coronavirus infections Alaska Dispatch News
Mayo Clinic
FDA approves clinical trial of cold plasma "scalpel" for cancer treatment newatlas.com
Earth
Azar rejects claims Trump pressured FDA to approve convalescent plasma coronavirus treatment Fox News
National Institutes of Health: American With Ebola In Critical Condition theledger.com
Liberia , Nebraska , Africa , Dallas , Infectious Diseases
National Institutes of Health Makes 'Shrine' to Anthony Fauci breitbart.com
RBiden announces nomination for director of National Institutes of Health rssfeeds.kvue.com
FDA Commissioner botched risk numbers when talking about post-COVID plasma Ars Technica
Trump announces plasma treatment auth...Shropshire Star